Selected research
Industry Research
Pharma Cold Chain Logistics Management Industry Research Report 2026
Market perspective
The global Pharma Cold Chain Logistics Management market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharma Cold Chain Logistics Management market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharma Cold Chain Logistics Management market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharma Cold Chain Logistics Management market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharma Cold Chain Logistics Management include Biocair, UPS, Maersk, World Courier, Kuehne + Nagel, DHL, Nippon Express, FedEx and C.H. Robinson, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharma Cold Chain Logistics Management market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharma Cold Chain Logistics Management.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharma Cold Chain Logistics Management Market by Company
Biocair
UPS
Maersk
World Courier
Kuehne + Nagel
DHL
Nippon Express
FedEx
C.H. Robinson
DSV
OOCL Logistics
Kerry Logistics
AIT Worldwide Logistics
Air Canada Cargo
BioLife Solutions
HKIA Cargo Intelligent Portal
CDMO World
Shengsheng Pharmaceutical Cold Chain
Jointown Pharmaceutical Group
SF Express
Pharma Cold Chain Logistics Management Segment by Type
Pharmaceutical Cold Chain Logistics Management
Vaccine Cold Chain Logistics Management
Cell Therapy/Gene Therapy Cold Chain Logistics Management
Pharma Cold Chain Logistics Management Segment by Application
Vaccine Manufacturers
Biopharmaceutical companies
Cell Therapy/GENE Therapy (CGT) Companies
CDMO/CMO Companies
Others
Pharma Cold Chain Logistics Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Cold Chain Logistics Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Cold Chain Logistics Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Cold Chain Logistics Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharma Cold Chain Logistics Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Cold Chain Logistics Management
- Vaccine Cold Chain Logistics Management
- Cell Therapy/Gene Therapy Cold Chain Logistics Management
Applications
- Vaccine Manufacturers
- Biopharmaceutical companies
- Cell Therapy/GENE Therapy (CGT) Companies
- CDMO/CMO Companies
- Others
Companies covered
- Biocair
- UPS
- Maersk
- World Courier
- Kuehne + Nagel
- DHL
- Nippon Express
- FedEx
- C.H. Robinson
- DSV
- OOCL Logistics
- Kerry Logistics
- AIT Worldwide Logistics
- Air Canada Cargo
- BioLife Solutions
- HKIA Cargo Intelligent Portal
- CDMO World
- Shengsheng Pharmaceutical Cold Chain
- Jointown Pharmaceutical Group
- SF Express
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharma Cold Chain Logistics Management by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Pharmaceutical Cold Chain Logistics Management
- 2.2.3 Vaccine Cold Chain Logistics Management
- 2.2.4 Cell Therapy/Gene Therapy Cold Chain Logistics Management
- 2.3 Pharma Cold Chain Logistics Management by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Vaccine Manufacturers
- 2.3.3 Biopharmaceutical companies
- 2.3.4 Cell Therapy/GENE Therapy (CGT) Companies
- 2.3.5 CDMO/CMO Companies
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Pharma Cold Chain Logistics Management Breakdown Data by Type
- 3.1 Global Pharma Cold Chain Logistics Management Historic Market Size by Type (2021-2026)
- 3.2 Global Pharma Cold Chain Logistics Management Forecasted Market Size by Type (2027-2032)
4 Pharma Cold Chain Logistics Management Breakdown Data by Application
- 4.1 Global Pharma Cold Chain Logistics Management Historic Market Size by Application (2021-2026)
- 4.2 Global Pharma Cold Chain Logistics Management Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharma Cold Chain Logistics Management Market Perspective (2021-2032)
- 5.2 Global Pharma Cold Chain Logistics Management Growth Trends by Region
- 5.2.1 Global Pharma Cold Chain Logistics Management Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharma Cold Chain Logistics Management Historic Market Size by Region (2021-2026)
- 5.2.3 Pharma Cold Chain Logistics Management Forecasted Market Size by Region (2027-2032)
- 5.3 Pharma Cold Chain Logistics Management Market Dynamics
- 5.3.1 Pharma Cold Chain Logistics Management Industry Trends
- 5.3.2 Pharma Cold Chain Logistics Management Market Drivers
- 5.3.3 Pharma Cold Chain Logistics Management Market Challenges
- 5.3.4 Pharma Cold Chain Logistics Management Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharma Cold Chain Logistics Management Players by Revenue
- 6.1.1 Global Top Pharma Cold Chain Logistics Management Players by Revenue (2021-2026)
- 6.1.2 Global Pharma Cold Chain Logistics Management Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharma Cold Chain Logistics Management Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharma Cold Chain Logistics Management Head Office and Area Served
- 6.4 Global Pharma Cold Chain Logistics Management Players, Product Type & Application
- 6.5 Global Pharma Cold Chain Logistics Management Manufacturers Established Date
- 6.6 Global Pharma Cold Chain Logistics Management Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharma Cold Chain Logistics Management Market Size (2021-2032)
- 7.2 North America Pharma Cold Chain Logistics Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharma Cold Chain Logistics Management Market Size by Country (2021-2026)
- 7.4 North America Pharma Cold Chain Logistics Management Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharma Cold Chain Logistics Management Market Size (2021-2032)
- 8.2 Europe Pharma Cold Chain Logistics Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharma Cold Chain Logistics Management Market Size by Country (2021-2026)
- 8.4 Europe Pharma Cold Chain Logistics Management Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharma Cold Chain Logistics Management Market Size (2021-2032)
- 9.2 Asia-Pacific Pharma Cold Chain Logistics Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharma Cold Chain Logistics Management Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharma Cold Chain Logistics Management Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharma Cold Chain Logistics Management Market Size (2021-2032)
- 10.2 South America Pharma Cold Chain Logistics Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharma Cold Chain Logistics Management Market Size by Country (2021-2026)
- 10.4 South America Pharma Cold Chain Logistics Management Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharma Cold Chain Logistics Management Market Size (2021-2032)
- 11.2 Middle East & Africa Pharma Cold Chain Logistics Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharma Cold Chain Logistics Management Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharma Cold Chain Logistics Management Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Biocair
- 12.1.1 Biocair Company Information
- 12.1.2 Biocair Business Overview
- 12.1.3 Biocair Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.1.4 Biocair Pharma Cold Chain Logistics Management Product Portfolio
- 12.1.5 Biocair Recent Developments
- 12.2 UPS
- 12.2.1 UPS Company Information
- 12.2.2 UPS Business Overview
- 12.2.3 UPS Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.2.4 UPS Pharma Cold Chain Logistics Management Product Portfolio
- 12.2.5 UPS Recent Developments
- 12.3 Maersk
- 12.3.1 Maersk Company Information
- 12.3.2 Maersk Business Overview
- 12.3.3 Maersk Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.3.4 Maersk Pharma Cold Chain Logistics Management Product Portfolio
- 12.3.5 Maersk Recent Developments
- 12.4 World Courier
- 12.4.1 World Courier Company Information
- 12.4.2 World Courier Business Overview
- 12.4.3 World Courier Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.4.4 World Courier Pharma Cold Chain Logistics Management Product Portfolio
- 12.4.5 World Courier Recent Developments
- 12.5 Kuehne + Nagel
- 12.5.1 Kuehne + Nagel Company Information
- 12.5.2 Kuehne + Nagel Business Overview
- 12.5.3 Kuehne + Nagel Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.5.4 Kuehne + Nagel Pharma Cold Chain Logistics Management Product Portfolio
- 12.5.5 Kuehne + Nagel Recent Developments
- 12.6 DHL
- 12.6.1 DHL Company Information
- 12.6.2 DHL Business Overview
- 12.6.3 DHL Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.6.4 DHL Pharma Cold Chain Logistics Management Product Portfolio
- 12.6.5 DHL Recent Developments
- 12.7 Nippon Express
- 12.7.1 Nippon Express Company Information
- 12.7.2 Nippon Express Business Overview
- 12.7.3 Nippon Express Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.7.4 Nippon Express Pharma Cold Chain Logistics Management Product Portfolio
- 12.7.5 Nippon Express Recent Developments
- 12.8 FedEx
- 12.8.1 FedEx Company Information
- 12.8.2 FedEx Business Overview
- 12.8.3 FedEx Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.8.4 FedEx Pharma Cold Chain Logistics Management Product Portfolio
- 12.8.5 FedEx Recent Developments
- 12.9 C.H. Robinson
- 12.9.1 C.H. Robinson Company Information
- 12.9.2 C.H. Robinson Business Overview
- 12.9.3 C.H. Robinson Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.9.4 C.H. Robinson Pharma Cold Chain Logistics Management Product Portfolio
- 12.9.5 C.H. Robinson Recent Developments
- 12.10 DSV
- 12.10.1 DSV Company Information
- 12.10.2 DSV Business Overview
- 12.10.3 DSV Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.10.4 DSV Pharma Cold Chain Logistics Management Product Portfolio
- 12.10.5 DSV Recent Developments
- 12.11 OOCL Logistics
- 12.11.1 OOCL Logistics Company Information
- 12.11.2 OOCL Logistics Business Overview
- 12.11.3 OOCL Logistics Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.11.4 OOCL Logistics Pharma Cold Chain Logistics Management Product Portfolio
- 12.11.5 OOCL Logistics Recent Developments
- 12.12 Kerry Logistics
- 12.12.1 Kerry Logistics Company Information
- 12.12.2 Kerry Logistics Business Overview
- 12.12.3 Kerry Logistics Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.12.4 Kerry Logistics Pharma Cold Chain Logistics Management Product Portfolio
- 12.12.5 Kerry Logistics Recent Developments
- 12.13 AIT Worldwide Logistics
- 12.13.1 AIT Worldwide Logistics Company Information
- 12.13.2 AIT Worldwide Logistics Business Overview
- 12.13.3 AIT Worldwide Logistics Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.13.4 AIT Worldwide Logistics Pharma Cold Chain Logistics Management Product Portfolio
- 12.13.5 AIT Worldwide Logistics Recent Developments
- 12.14 Air Canada Cargo
- 12.14.1 Air Canada Cargo Company Information
- 12.14.2 Air Canada Cargo Business Overview
- 12.14.3 Air Canada Cargo Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.14.4 Air Canada Cargo Pharma Cold Chain Logistics Management Product Portfolio
- 12.14.5 Air Canada Cargo Recent Developments
- 12.15 BioLife Solutions
- 12.15.1 BioLife Solutions Company Information
- 12.15.2 BioLife Solutions Business Overview
- 12.15.3 BioLife Solutions Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.15.4 BioLife Solutions Pharma Cold Chain Logistics Management Product Portfolio
- 12.15.5 BioLife Solutions Recent Developments
- 12.16 HKIA Cargo Intelligent Portal
- 12.16.1 HKIA Cargo Intelligent Portal Company Information
- 12.16.2 HKIA Cargo Intelligent Portal Business Overview
- 12.16.3 HKIA Cargo Intelligent Portal Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.16.4 HKIA Cargo Intelligent Portal Pharma Cold Chain Logistics Management Product Portfolio
- 12.16.5 HKIA Cargo Intelligent Portal Recent Developments
- 12.17 CDMO World
- 12.17.1 CDMO World Company Information
- 12.17.2 CDMO World Business Overview
- 12.17.3 CDMO World Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.17.4 CDMO World Pharma Cold Chain Logistics Management Product Portfolio
- 12.17.5 CDMO World Recent Developments
- 12.18 Shengsheng Pharmaceutical Cold Chain
- 12.18.1 Shengsheng Pharmaceutical Cold Chain Company Information
- 12.18.2 Shengsheng Pharmaceutical Cold Chain Business Overview
- 12.18.3 Shengsheng Pharmaceutical Cold Chain Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.18.4 Shengsheng Pharmaceutical Cold Chain Pharma Cold Chain Logistics Management Product Portfolio
- 12.18.5 Shengsheng Pharmaceutical Cold Chain Recent Developments
- 12.19 Jointown Pharmaceutical Group
- 12.19.1 Jointown Pharmaceutical Group Company Information
- 12.19.2 Jointown Pharmaceutical Group Business Overview
- 12.19.3 Jointown Pharmaceutical Group Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.19.4 Jointown Pharmaceutical Group Pharma Cold Chain Logistics Management Product Portfolio
- 12.19.5 Jointown Pharmaceutical Group Recent Developments
- 12.20 SF Express
- 12.20.1 SF Express Company Information
- 12.20.2 SF Express Business Overview
- 12.20.3 SF Express Revenue in Pharma Cold Chain Logistics Management Business (2021-2026)
- 12.20.4 SF Express Pharma Cold Chain Logistics Management Product Portfolio
- 12.20.5 SF Express Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst